Rev Run, Rapper, Minister, Former Kool-Aid Brand Ambassador: Now Diabetes Screening Spokesperson for Novo...

Novo Nordisk has gone through the PR wringer over its choice of Krispy Creme donut loving celebrity chef Paula Deen as its Victoza diabetes...

Should Novo Nordisk Dump Deen?

UPDATE (27 June 2013): Novo Nordisk "Dumps" ... err, "Suspends" Deen: "Novo Nordisk and Paula Deen have mutually agreed to suspend our patient education activities...

Overcoming Pharma’s Social Media Challenges: My Roche Digital Academy Presentation

I spent the last two weeks or so touring Germany and Italy -- specifically Berlin, Munich, and Milan -- stopping along the way to...

Pharmaguy EU Tour 2013 – The Infographic

The following infographic was created as I was making my presentation -- "Overcoming Pharma's Social Media & Mobile Challenges" -- at Bayer Healthcare in...

Bayer Pharma Meets Pharmaguy Meets Healthcare App Startups: A Call for Best Practices

In a couple of days I will be leaving for the "Pharmaguy European Tour 2013." I will visit Berlin, Munich, and Milan and return on...

How Did the uChek iPhone Urine Analysis App “Come to FDA’s Attention?”

"An iPhone application that lets users check levels of blood, protein and other substances in their urine is the first target of U.S. regulators...

Another BI “Educational” Game That I Don’t Get — Literally!

Have you heard that Boehringer Ingelheim (BI) and Lilly have "stepped up their joint efforts to raise awareness of diabetes, launching the new educational...

J&J Embraces “Special K” for Depression – Why Not Medical Marijuana?

Current antidepressants take weeks or months to have an effect, and then only in 30% of patients, notes Matthew Herper, Forbes, in a recent...

Tablet Detailing Evolution According to Roche Italy

I'm preparing for my presentation at the Roche Digital Academy in Milan on June 19, 2013 (see "Pharmaguy to Present at the Roche Digital...

Should Pharma Do Tumblr?

Peter Houston (@Flipping_Pages) asked "Could Pharma Do Tumblr?" in a guest post to PharmExecBlog (here). "I’m not suggesting that anyone switch their social media...